RPS Support Alerts

The RPS Support team are developing and publishing regular Support Alerts to help support you in your day to day roles. These will cover a wide range of subjects ranging from legal and ethical issues to clinical matters and aim to be informative, supportive and user-friendly. Topics will be identified as part of horizon scanning by the RPS Support team but will also be produced in response to real queries and issues raised by members.

This section also includes information about drug and device recalls, patient safety notices, health professional letters and other important communications concerning patient safety, thus enabling you to ensure that you meet any necessary clinical governance requirements.

To receive these alerts via email please subscribe by visiting My Preferences.

You can choose to view older Support Alerts by using the filter options in the Support Alert Archive box below and selecting specific a month or year.

Support Alerts archive

29/06/2015 - Class 4 Drug Alert: Xenidate XL 36mg prolonged-release tablets 

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 drug alert: medicines .....more 

29/06/2015 - Drug Safety Update: SGLT2 inhibitors  

Drug Safety Update: SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk .....more 

17/06/2015 - Asthma UK report - Patient safety failure in asthma care. Further advice. 

The Chief Medical Officer and the Chief Pharmaceutical Officer for Wales have issued a statement .....more 

16/06/2015 - CAS alert: MERS-CoV outbreak in South Korea - further update 

CAS alert: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) outbreak in South Korea .....more 

16/06/2015 - New mandatory logo for selling medicines online 

The Medicines and Healthcare Products Regulatory Agency (MHRA) have issued a press release advising .....more 

05/06/2015 - CAS alert: Update on MERS Coronavirus Infection 

The Chief Medical Officer has issued an alert to provide an update on MERS Coronavirus Infection. .....more